Ascendis Pharma Current Deferred Revenue (Quarterly) Analysis

Ascendis Pharma A/S (ASND)

211.02 +2.04 (+0.98%) USD | NASDAQ | Dec 29, 16:00

212.89 +1.87 (+0.89%) Pre-Market: 09:07

View Current Deferred Revenue (Quarterly) for ASND.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial